Wed, August 25, 2021
Tue, August 24, 2021
Mon, August 23, 2021
Fri, August 20, 2021
Thu, August 19, 2021
Wed, August 18, 2021
Tue, August 17, 2021
Mon, August 16, 2021
Sun, August 15, 2021
Fri, August 13, 2021

Matthew Harrison Maintained (TSHA) at Buy with Decreased Target to $39 on, Aug 18th, 2021


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-39-on-aug-18th-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Matthew Harrison of Morgan Stanley, Maintained "Taysha Gene Therapies, Inc." (TSHA) at Buy with Decreased Target from $43 to $39 on, Aug 18th, 2021.

Matthew has made no other calls on TSHA in the last 4 months.



There are 7 other peers that have a rating on TSHA. Out of the 7 peers that are also analyzing TSHA, 0 agree with Matthew's Rating of Hold.



These are the ratings of the 7 analyists that currently disagree with Matthew


  • Geulah Livshits of "Chardan Capital" Maintained at Strong Buy with Decreased Target to $60 on, Tuesday, August 17th, 2021
  • Gil Blum of "Needham" Initiated at Strong Buy and Held Target at $45 on, Friday, July 16th, 2021
  • Joon Lee of "Truist Securities" Initiated at Strong Buy and Held Target at $60 on, Thursday, June 24th, 2021
  • Yun Zhong of "BTIG" Initiated at Strong Buy and Held Target at $44 on, Tuesday, June 15th, 2021
  • Laura Chico of "Wedbush" Initiated at Buy and Held Target at $31 on, Wednesday, June 9th, 2021
  • Silvan Tuerkcan of "JMP Securities" Initiated at Buy and Held Target at $40 on, Tuesday, June 8th, 2021
  • Kristen Kluska of "Cantor Fitzgerald" Initiated at Buy and Held Target at $44 on, Wednesday, May 19th, 2021

Publication Contributing Sources